ACCP SEEK 23 SET 5 Flashcards
DAD DUE TO EGFR TYROSINE KINASE INHIBITORS
QUESTION 37
DISCONTINUE EGFR TYROSINE KINASE INHIBITORS
INDWELLING PLEURAL CATHETERS
HOSPITALIZATION DURING IPC PLACEMENT IS SIGNIFICANTLY DECREASED COMPARED TO PLEURODESIS
SPONTANEOUS RESOLUTION IN 47%
NO SIGNIFICANT DIFFERENCES IN CHEST PAIN OR QOL
INFECTION HAPPENS LATE > 50 DAYS
TREATMENT OF STABLE LOW RISK COPD
SHORT ACTING BETA AGONIST
CMV PNEUMONIA QUESTION 34
FOLLOWS BMT
WITHIN 100 DAYS
INCIDENCE IS 10-40%
RISKS: ALLOGENEIC TRANSPLANT, AGE, VIRUS TITER
BEST WAY TO DX: ANTGEN TESTS
HALLMARK: LARGE OWLS EYE INCLUSION BODIES
CMV INFECTION IS ASSOCIATED WITH BRONCHIOLITIS OBLITERANS
METHOTREXATE LUNG
ALVEOLITIS, EOSINOPHILIC INFILTRATES
VTE IN CANCER
PREDICTOR OF INCREASED MORTALITY
SHOULD BE ON LMWH AND NOT CONVERTED TO WARFARIN
>= 3 MONTHS
QUINOLONES AND TB
SHORT TERM QUINOLONE USE IS NOT ASSOCIATED WITH RESISTANCE IN TB
AMMONIA GAS EXPOSURE
AMMONIA IS WATER SOLUBLE
LOW DOSE: OBSERVE FOR 12 HOURS.
HIGH EXPOSURE: SEVERE ARIWAY IRRITATION, EDEMA AND BRONCHOSPASM CAN OCCUR AND AIRWAY PROTECTION IS ESSENTIAL
BLASTOMYCOSIS QUESTION 32
ITRACONAZOLE FOR MILD DISEASE IF PT HAS NO MENINGITIS, BUT LUNG INVOLVEMENT, SKIN INVOLVEMENT AND NOT RESP FAILURE 24 WEEKS OF TREATMENT AMPHOTERICIN FOR SEVERE DISEASE: ARDS OR MENINGITIS
TREATMENT FOR ACTINOMYCES
PCN G
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
QUESTION 33
OCCURS IN LUNG TRANSPLANTS MORE THAN OTHER ORGANS
B CELL NHL IS MOST COMMON. ASSOCIATED WITH EBV
RADIOGRAPHIC: SOLITARY OR MULTIPLE NODULES
TREATMENT: REDUCE IMMUNOSUPPRESION AND RITUXIMAB, ANTI-CD20 MONOCLONAL ANTIBODY
ACUTE REJECTION
OCCURS IN FIRST YEAR FOLLOWiNG TRANSPLANT
PATHOLOGY: LYMPHOCYTIC VASCULITIS
TREATMENT: INCREASE IMMUNOSUPPRESION
ALSO FOR CHRONIC REJECITON: BO
ARDS DEFINITION
BILATERAL OPACITIES CONSISTENT WITH PULMONARY EDEMA MUST BE PRESENT
PO2/FIO2 CAN BE AS HIGH AS 300
A1AT DEFICIENCY
CANNOT GIVE AUGMENTATION IF PT IS STILL SMOKING